Ticker Symbol: WVE
Wave Life Sciences Ltd.
$4.40 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
Singapore
Currency:
USD
Asset
Type: Common Stock
CIK:0001631574
Company Profile
Wave Life Sciences is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company's proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: www.wavelifesciences.com
CEO: Paul Bolno
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $5.84
Change:
-$0.18
(
-2.99%)
Days Range: $5.65 - $6.09
Beta: 1.21
52wk. High: $7.12
52wk. Low: $3.04
Ytd. Change -16.99%
50 Day Moving Average: $5.36
200 Day Moving Average: $4.45
Shares Outstanding: 98983261
Valuation
Market Cap: 57.8B
PE Ratio: -4.39
EPS (TTM): -1.33
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A